AstraZeneca
AZN
AZN
601 hedge funds and large institutions have $19.8B invested in AstraZeneca in 2020 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 199 increasing their positions, 223 reducing their positions, and 85 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
11% less repeat investments, than reductions
Existing positions increased: 199 | Existing positions reduced: 223
11% less capital invested
Capital invested by funds: $22.3B → $19.8B (-$2.53B)
29% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 85
Holders
601
Holding in Top 10
13
Calls
$88.9M
Puts
$90.8M
Top Buyers
| 1 | +$240M | |
| 2 | +$131M | |
| 3 | +$98.8M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$96.6M |
| 5 |
Jennison Associates
New York
|
+$95.9M |
Top Sellers
| 1 | -$384M | |
| 2 | -$217M | |
| 3 | -$142M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$95.6M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$90.4M |